© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
Featured Content
Highlighted Videos
Episode 62: The Future of Pharma’s Supply Chain
August 06, 2020
Kurt Orlofski, CEO of Pharmaceutical Associates Inc., discusses what the pharmaceutical supply chain might look like post COVID-19, and how companies can prepare for that.
Success Factors for Orphan Drug Development
August 04, 2020
When approached correctly, drug development in the rare disease space can be quite successful – especially when powerhouses across the industry join forces and leverage the power of data to help drive potential treatment options.
What Makes for a Great Leader in Pharma, and How to Hire One
August 04, 2020
A look into the traits that hiring managers of pharma companies should be searching for when hiring for a leadership role.
Unlock Real World Evidence with Pragmatic Data Governance and Quality Practices
August 04, 2020
How companies are leveraging Real Word Evidence to evaluate therapies under real world conditions in a broader population at a lower cost than using Randomized Clinical Trials.
How COVID-19 Has Affected Launches of New Oncology Therapies in the U.S.
August 04, 2020
Several months into the COVID-19 pandemic, this article takes a look back at how the launches of new oncology therapies have been impacted.
Debate Accelerates Over Who Gets COVID Vaccine First
August 03, 2020
As biopharma companies and research institutes advance the development of promising vaccines against COVID-19, policy makers and health officials have intensified deliberations on strategies for ensuring fair and equitable distribution of anticipated preventives.
EU Medical Device Supply Chains and Trade Agreements: The COVID-19 Response
August 02, 2020
Andrew Hood and Cliodhna McDonough look at the key issues necessary to support business and the community in developing a long-term and sustainable response to the challenges highlighted by COVID-19.
IQVIA Launches New OCE Optimizer
July 30, 2020
IQVIA has announced the launch of OCE Optimizer, which will look to help life sciences companies reach HCPs more effectively.
Support Your Clinical and Economic Value Proposition with Real World Data: Data and technology-enabled evidence generation
July 30, 2020
Healthcare decision-makers have become increasingly aware of the need to utilize real world data (RWD) to better-understand treatment patterns, disease burden, and the impact of interventions from both a clinical and cost perspective. Join IQVIA to learn more about the pivotal role RWD now plays in informing decisions about access and reimbursement, drug safety, and comparative effectiveness. Live: Thursday, Aug. 20, 2020 at 2pm EDT On demand available after airing until Aug. 20, 2021.